This inventor holds 5 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Idenix Pharmaceuticals, Inc., Merck Sharp + Dohme Corp.. Active years: 2013-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montpellier, FR (2013 - 2019)
- Grabels, FR (2021)
Company Filing History:
5 out of 100 
1 out of 2,405 
Years Active: 2013-2021
Title: Revolutionizing Viral Treatments: The Innovations of Guillaume Brandt
Introduction
Guillaume Brandt, an innovative inventor based in Montpellier, France, has made significant contributions to the field of virology through his groundbreaking patent work. With a total of five patents to his name, Brandt focuses on developing advanced nucleoside compounds that have the potential to treat various viral diseases.
Latest Patents
Brandt's latest patents include two notable inventions:
1. **Cyclic Phosphate Substituted Nucleoside Compounds and Methods of Use Thereof for the Treatment of Viral Diseases**
This invention features cyclic phosphate substituted nucleoside compounds that can be used for treating or preventing HCV infection in patients. The compounds, identified by specific formulas, are also related to pharmaceutically acceptable salts and various compositions containing these compounds.
2. **Amino Acid Phosphoramidate Pronucleotides of 2'-Cyano, Azido and Amino Nucleosides for the Treatment of HCV**
In this patent, Brandt describes compounds and methods designed to target Flaviviridae infections, such as HCV. The disclosed nucleoside derivatives can be utilized alone or in conjunction with other antiviral agents, showcasing their potential to enhance therapeutic effectiveness.
Career Highlights
Throughout his career, Guillaume Brandt has worked with esteemed companies in the pharmaceutical industry, including Idenix Pharmaceuticals, Inc. and Merck Sharp & Dohme Corporation. His experience at these organizations has equipped him with the expertise necessary to drive innovations in antiviral drug development.
Collaborations
In his journey as an inventor, Brandt has collaborated with notable colleagues such as Cyril B Dousson and David Dukhan. These partnerships underscore the importance of teamwork in advancing scientific research and developing new therapeutic strategies.
Conclusion
Guillaume Brandt is a distinguished inventor whose work is paving the way for new treatment options for viral infections. Through his innovative patents and collaborations, he continues to make a meaningful impact in the field of virology, offering hope for effective therapies against challenging diseases like HCV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile